Chemotherapeutic agents increased the levels of IL-2, IL-6, interferon-gamma (INF-γ) and decreased the production of IL-1 and tumour necrosis factor-alpha (TNF-α) in women with advanced breast cancer who responded to treatment [27]. This evidence concerns the gene IL6 and breast cancer.